Samsung SCH U340 User Manual (ENGLISH) - Page 93

What is FDA's role concerning the safety of wireless phones?, Communications Commission FCC.

Page 93 highlights

of RF when in the stand-by mode. Whereas high levels of RF can produce health effects (by heating tissue), exposure to low level RF that does not produce heating effects causes no known adverse health effects. Many studies of low level RF exposures have not found any biological effects. Some studies have suggested that some biological effects may occur, but such findings have not been confirmed by additional research. In some cases, other researchers have had difficulty in reproducing those studies, or in determining the reasons for inconsistent results. What is FDA's role concerning the safety of wireless phones? Under the law, FDA does not review the safety of radiation-emitting consumer products such as wireless phones before they can be sold, as it does with new drugs or medical devices. However, the agency has authority to take action if wireless phones are shown to emit radio frequency energy (RF) at a level that is hazardous to the user. In such a case, FDA could require the manufacturers of wireless phones to notify users of the health hazard and to repair, replace or recall the phones so that the hazard no longer exists. Although the existing scientific data do not justify FDA regulatory actions, FDA has urged the wireless phone industry to take a number of steps, including the following: • Support needed research into possible biological effects of RF of the type emitted by wireless phones; • Design wireless phones in a way that minimizes any RF exposure to the user that is not necessary for device function; and • Cooperate in providing users of wireless phones with the best possible information on possible effects of wireless phone use on human health. FDA belongs to an interagency working group of the federal agencies that have responsibility for different aspects of RF safety to ensure coordinated efforts at the federal level. The following agencies belong to this working group: • National Institute for Occupational Safety and Health • Environmental Protection Agency • Federal Communications Commission • Occupational Safety and Health Administration • National Telecommunications and Information Administration The National Institutes of Health participates in some interagency working group activities, as well. FDA shares regulatory responsibilities for wireless phones with the Federal Communications Commission (FCC). All phones that are sold in the United States Section 11: Health and Safety Information 90

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114

Section 11: Health and Safety Information
90
of RF when in the stand-by mode.
Whereas high levels of RF can produce health
effects (by heating tissue), exposure to low level RF that does not produce heating
effects causes no known adverse health effects.
Many studies of low level RF
exposures have not found any biological effects.
Some studies have suggested that
some biological effects may occur, but such findings have not been confirmed by
additional research.
In some cases, other researchers have had difficulty in
reproducing those studies, or in determining the reasons for inconsistent results.
What is FDA's role concerning the safety of wireless phones?
Under the law, FDA does not review the safety of radiation-emitting consumer
products such as wireless phones before they can be sold, as it does with new drugs
or medical devices.
However, the agency has authority to take action if wireless
phones are shown to emit radio frequency energy (RF) at a level that is hazardous to
the user.
In such a case, FDA could require the manufacturers of wireless phones to
notify users of the health hazard and to repair, replace or recall the phones so that
the hazard no longer exists.
Although the existing scientific data do not justify FDA regulatory actions, FDA has
urged the wireless phone industry to take a number of steps, including the following:
• Support needed research into possible biological effects of RF of the type
emitted by wireless phones;
• Design wireless phones in a way that minimizes any RF exposure to the user
that is not necessary for device function; and
• Cooperate in providing users of wireless phones with the best possible
information on possible effects of wireless phone use on human health.
FDA belongs to an interagency working group of the federal agencies that have
responsibility for different aspects of RF safety to ensure coordinated efforts at the
federal level.
The following agencies belong to this working group:
• National Institute for Occupational Safety and Health
• Environmental Protection Agency
• Federal Communications Commission
• Occupational Safety and Health Administration
• National Telecommunications and Information Administration
The National Institutes of Health participates in some interagency working group
activities, as well.
FDA shares regulatory responsibilities for wireless phones with the Federal
Communications Commission (FCC).
All phones that are sold in the United States